Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Collegium Pharmaceutical (COLL)

Collegium posts record Q4 revenue of $181.9 million; general counsel to step down

Mixed Impact 3 of 5 earnings Written later

Collegium reported record fourth-quarter and full-year 2024 product revenues and reaffirmed its 2025 guidance. Q4 GAAP net income fell to $12.5 million from $31.9 million a year earlier, though full-year GAAP net income rose to $69.2 million from $48.2 million. Shirley Kuhlmann, executive vice president, chief administrative officer, general counsel and secretary, will leave the company effective March 7, 2025.

Key points

  • Q4 product revenues, net were $181.9 million, up 22% from $149.7 million; Q4 GAAP diluted EPS was $0.36 versus $0.82 a year earlier
  • Full-year 2024 product revenues, net were $631.4 million, up 11%; full-year GAAP net income was $69.2 million versus $48.2 million
  • 2025 guidance reaffirmed: product revenues, net of $735.0 to $750.0 million and adjusted EBITDA of $435.0 to $450.0 million
  • Shirley Kuhlmann steps down effective March 7, 2025; her departure is treated as a termination without cause under her existing employment agreement

The filing

CompanyCollegium Pharmaceutical (COLL)
Form8-K, current report
Filed with the SECFeb 27, 2025, 4:01 PM ET
Accession number0001558370-25-001799

Items reported: 2.02 Results of Operations5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 2:07 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.